Literature DB >> 28385374

Central immune tolerance depends on crosstalk between the classical and alternative NF-κB pathways in medullary thymic epithelial cells.

Marc Riemann1, Nico Andreas2, Maria Fedoseeva2, Elke Meier2, Debra Weih2, Helga Freytag2, Ruth Schmidt-Ullrich3, Ulf Klein4, Zhao-Qi Wang5, Falk Weih2.   

Abstract

Medullary thymic epithelial cells (mTECs) contribute to self-tolerance by expressing and presenting peripheral tissue antigens for negative selection of autoreactive T cells and differentiation of natural regulatory T cells. The molecular control of mTEC development remains incompletely understood. We here demonstrate by TEC-specific gene manipulation in mice that the NF-κB transcription factor subunit RelB, which is activated by the alternative NF-κB pathway, regulates development of mature mTECs in a dose-dependent manner. Mice with conditional deletion of Relb lacked mature mTECs and developed spontaneous autoimmunity. In addition, the NF-κB subunits RelA and c-Rel, which are both activated by classical NF-κB signaling, were jointly required for mTEC differentiation by directly regulating the transcription of Relb. Our data reveal a crosstalk mechanism between classical and alternative NF-κB pathways that tightly controls the development of mature mTECs to ensure self-tolerance.
Copyright © 2017 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Autoimmunity; Central immune tolerance; Conditional gene targeting; Medullary thymic epithelial cells; NF-κB

Mesh:

Substances:

Year:  2017        PMID: 28385374     DOI: 10.1016/j.jaut.2017.03.007

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  19 in total

1.  The long and latent road to autoimmunity.

Authors:  Carlo Selmi; M Eric Gershwin
Journal:  Cell Mol Immunol       Date:  2018-03-22       Impact factor: 11.530

2.  RelB Deficiency in Dendritic Cells Protects from Autoimmune Inflammation Due to Spontaneous Accumulation of Tissue T Regulatory Cells.

Authors:  Nico Andreas; Maria Potthast; Anna-Lena Geiselhöringer; Garima Garg; Renske de Jong; Julia Riewaldt; Dennis Russkamp; Marc Riemann; Jean-Philippe Girard; Simon Blank; Karsten Kretschmer; Carsten Schmidt-Weber; Thomas Korn; Falk Weih; Caspar Ohnmacht
Journal:  J Immunol       Date:  2019-10-02       Impact factor: 5.422

Review 3.  NF-κB in control of regulatory T cell development, identity, and function.

Authors:  Nadine Hövelmeyer; Marc Schmidt-Supprian; Caspar Ohnmacht
Journal:  J Mol Med (Berl)       Date:  2022-06-08       Impact factor: 5.606

4.  Changes in expression of nuclear factor kappa B subunits in the ovine thymus during early pregnancy.

Authors:  Ling Yang; Chunjiang Cai; Shengya Fang; Shaopeng Hao; Taipeng Zhang; Leying Zhang
Journal:  Sci Rep       Date:  2022-10-21       Impact factor: 4.996

Review 5.  Epidermal resident γδ T cell development and function in skin.

Authors:  Yingping Xu; Peter Dimitrion; Steven Cvetkovski; Li Zhou; Qing-Sheng Mi
Journal:  Cell Mol Life Sci       Date:  2020-08-17       Impact factor: 9.261

6.  Lymphotoxin α fine-tunes T cell clonal deletion by regulating thymic entry of antigen-presenting cells.

Authors:  Noëlla Lopes; Jonathan Charaix; Oriane Cédile; Arnauld Sergé; Magali Irla
Journal:  Nat Commun       Date:  2018-03-28       Impact factor: 14.919

Review 7.  Nuclear Factor-kappaB in Autoimmunity: Man and Mouse.

Authors:  Bahar Miraghazadeh; Matthew C Cook
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

Review 8.  Twenty Years of AIRE.

Authors:  Roberto Perniola
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

9.  A novel mechanism of tumor-induced thymic atrophy in mice bearing H22 hepatocellular carcinoma.

Authors:  Sujun Sun; Haiyu Ji; Yingying Feng; Yu Kang; Juan Yu; Anjun Liu
Journal:  Cancer Manag Res       Date:  2018-03-05       Impact factor: 3.989

10.  The transcription factor RelB restrains group 2 innate lymphoid cells and type 2 immune pathology in vivo.

Authors:  Lei Zhang; Yuanlin Ying; Shuqiu Chen; Preston R Arnold; Fafa Tian; Laurie J Minze; Xiang Xiao; Xian C Li
Journal:  Cell Mol Immunol       Date:  2020-03-19       Impact factor: 11.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.